115 related articles for article (PubMed ID: 12069503)
1. Somatostatin receptor subtype 2 gene therapy inhibits pancreatic cancer in vitro.
Fisher WE; Wu Y; Amaya F; Berger DH
J Surg Res; 2002 Jun; 105(1):58-64. PubMed ID: 12069503
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
[TBL] [Abstract][Full Text] [Related]
3. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide.
Fisher WE; Muscarella P; O'Dorisio TM; O'Dorisio MS; Kim JA; Doran TA; Sabourin CL; Schirmer WJ
Surgery; 1996 Aug; 120(2):234-40; discussion 240-1. PubMed ID: 8751588
[TBL] [Abstract][Full Text] [Related]
4. Transfection of SSTR-1 and SSTR-2 inhibits Panc-1 cell proliferation and renders Panc-1 cells responsive to somatostatin analogue.
Li M; Zhang R; Li F; Wang H; Kim HJ; Becnel L; Yao Q; Chen C; Fisher WE
J Am Coll Surg; 2005 Oct; 201(4):571-8. PubMed ID: 16183496
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
6. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.
Weber CK; Sommer G; Michl P; Fensterer H; Weimer M; Gansauge F; Leder G; Adler G; Gress TM
Gastroenterology; 2001 Sep; 121(3):657-67. PubMed ID: 11522750
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin is expressed in FRTL-5 thyroid cells and prevents thyrotropin-mediated down-regulation of the cyclin-dependent kinase inhibitor p27kip1.
Medina DL; Velasco JA; Santisteban P
Endocrinology; 1999 Jan; 140(1):87-95. PubMed ID: 9886811
[TBL] [Abstract][Full Text] [Related]
10. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
[TBL] [Abstract][Full Text] [Related]
11. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
12. Mechanical stress reduces podocyte proliferation in vitro.
Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2.
Kumar M; Liu ZR; Thapa L; Wang DY; Tian R; Qin RY
Pancreas; 2004 Aug; 29(2):141-51. PubMed ID: 15257106
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
15. Regulation of p21 and p27 expression by the hepatitis B virus X protein and the alternate initiation site X proteins, AUG2 and AUG3.
Leach JK; Qiao L; Fang Y; Han SL; Gilfor D; Fisher PB; Grant S; Hylemon PB; Peterson D; Dent P
J Gastroenterol Hepatol; 2003 Apr; 18(4):376-85. PubMed ID: 12653885
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models.
Vernejoul F; Faure P; Benali N; Calise D; Tiraby G; Pradayrol L; Susini C; Buscail L
Cancer Res; 2002 Nov; 62(21):6124-31. PubMed ID: 12414637
[TBL] [Abstract][Full Text] [Related]
17. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.
Li M; Li W; Kim HJ; Yao Q; Chen C; Fisher WE
J Surg Res; 2004 Jun; 119(2):130-7. PubMed ID: 15145694
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer.
Rochaix P; Delesque N; Estève JP; Saint-Laurent N; Voight JJ; Vaysse N; Susini C; Buscail L
Hum Gene Ther; 1999 Apr; 10(6):995-1008. PubMed ID: 10223733
[TBL] [Abstract][Full Text] [Related]
19. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
20. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
